Limitation and potential hazards of MAOI's for the treatment of depressive symptoms in abstinent alcoholics

Am J Drug Alcohol Abuse. 1989;15(3):339-44. doi: 10.3109/00952998908993413.
No abstract available

Publication types

  • Clinical Trial
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Alcoholism / complications*
  • Alcoholism / rehabilitation
  • Clinical Trials as Topic
  • Depression / drug therapy*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Monoamine Oxidase Inhibitors / adverse effects*
  • Monoamine Oxidase Inhibitors / therapeutic use
  • Phenelzine / adverse effects
  • Psychiatric Department, Hospital
  • Psychiatric Status Rating Scales
  • Random Allocation
  • Temperance*
  • Tranylcypromine / adverse effects

Substances

  • Monoamine Oxidase Inhibitors
  • Tranylcypromine
  • Phenelzine